Associated Papers
Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings.
Schmidt A et al.
Nature Genetics, 2024
39039281 (PubMed )
Supplement: 41588_2024_1836_MOESM4_ESM.xlsx › S1
IL4Rα and IL17A Blockade Rescue Autoinflammation in SOCS1 Haploinsufficiency.
Gruber C et al.
Journal of Clinical Immunology, 2023
TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era.
Landsburg DJ et al.
Blood Advances, 2023
37851898 (PubMed )
Supplement: BLOODA_ADV-2023-011384-mmc1.pdf
Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas.
Donzel M et al.
Cancers, 2023
37835560 (PubMed )
Supplement: cancers-15-04866-s001.zip › Suppl._Table._2.xlsx › Feuil1
Targeted panel sequencing in the routine diagnosis of mature T- and NK-cell lymphomas: report of 128 cases from two German reference centers.
Böck J et al.
Frontiers in Oncology, 2023
37664054 (PubMed )
Supplement: Table_1.xlsx › Table_S2
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study.
Camus V et al.
Haematologica, 2021
SOCS, SPRED, and NR4a: Negative regulators of cytokine signaling and transcription in immune tolerance.
Yoshimura A et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 2021
One Gene, Many Facets: Multiple Immune Pathway Dysregulation in SOCS1 Haploinsufficiency.
Körholz J et al.
Frontiers in Immunology, 2021
Whole-genome sequencing of a sporadic primary immunodeficiency cohort.
Thaventhiran JED et al.
Nature, 2020
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.
Schif B et al.
Oncotarget, 2013
23296022 (PubMed )
Supplement: oncotarget-04-035-s001.pdf
Select a paper to view details